TG Therapeutics (TGTX) Nyalo Cwiny me Stock
Lich me gik$57.44Oyiko 25 Sep 2026 19:59 UTC
Loko-0.12%
AI forecast: TGTX
AI otyeko kwena ya ceng ma lwenyo, gima agik juma, ki gima agik juma. Kwena en gima iyar ki neno kwena ma nyaka. Gin en neno ki kare, onyo nyutu ya yat.
Jaji e lweny e dwe 6 mag giko
Premium nyalo neno ceng'a AI me yweyo piyo ki 1 odiiyo, 1 juma ki 1 dwe ki gima onongo ki gikato ma okato.
Unlock Premium🔒 Nyinge yoo oryeto
Neno kare duto — forecast duto ma otyeko ki kwena ma otyeko — en pake Premium.
Unlock PremiumNyinge Aciya Man
TG Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in the acquisition, development, and commercialization of innovative pharmaceutical products for the treatment of cancer and other underserved diseases. The company is developing two treatments for hematologic malignancies, specifically relapsed and refractory non-Hodgkin lymphoma.
